Role of Noninvasive Testing in the Clinical Evaluation of Women With Suspected Ischemic Heart Disease
Published: June 16, 2014
- Under-treatment and under-testing in women lead to increased complications and to higher rate of case fatalities.
- Atherosclerotic coronary artery disease (CAD) continues to be underrecognized and underdiagnosed in women, contributing to the high mortality.
- This statement provides modern evidence to assist in identifying the appropriate female candidates for diagnostic testing.